Alzamend Neuro (NASDAQ:ALZN) Price Target Lowered to $20.00 at Ascendiant Capital Markets
Alzamend Neuro (NASDAQ:ALZN – Free Report) had its price target lowered by Ascendiant Capital Markets from $32.00 to $20.00 in a report published on Monday,Benzinga reports. The firm currently has a buy rating on the stock. Alzamend Neuro Trading Up 32.1 % Shares of ALZN opened at $0.89 on Monday. Alzamend Neuro has a 52 […]
